- Home
- CELZ vs SBFM Comparison
CELZ vs SBFM Comparison
Compare CELZ & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- SBFM
- Stock Information
- Founded
- CELZ 1998
- SBFM 2006
- Country
- CELZ United States
- SBFM United States
- Employees
- CELZ N/A
- SBFM N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- SBFM Health Care
- Exchange
- CELZ Nasdaq
- SBFM Nasdaq
- Market Cap
- CELZ 4.7M
- SBFM 4.3M
- IPO Year
- CELZ N/A
- SBFM N/A
- Fundamental
- Price
- CELZ $3.00
- SBFM $3.17
- Analyst Decision
- CELZ
- SBFM
- Analyst Count
- CELZ 0
- SBFM 0
- Target Price
- CELZ N/A
- SBFM N/A
- AVG Volume (30 Days)
- CELZ 11.1K
- SBFM 299.4K
- Earning Date
- CELZ 11-12-2024
- SBFM 11-11-2024
- Dividend Yield
- CELZ N/A
- SBFM N/A
- EPS Growth
- CELZ N/A
- SBFM N/A
- EPS
- CELZ N/A
- SBFM N/A
- Revenue
- CELZ $17,000.00
- SBFM $30,481,982.00
- Revenue This Year
- CELZ N/A
- SBFM $86.70
- Revenue Next Year
- CELZ N/A
- SBFM $126.76
- P/E Ratio
- CELZ N/A
- SBFM N/A
- Revenue Growth
- CELZ N/A
- SBFM 109.82
- 52 Week Low
- CELZ $2.65
- SBFM $2.42
- 52 Week High
- CELZ $10.28
- SBFM $740.00
- Technical
- Relative Strength Index (RSI)
- CELZ 44.19
- SBFM 49.27
- Support Level
- CELZ $2.94
- SBFM $2.83
- Resistance Level
- CELZ $3.15
- SBFM $3.75
- Average True Range (ATR)
- CELZ 0.22
- SBFM 0.28
- MACD
- CELZ -0.01
- SBFM 0.07
- Stochastic Oscillator
- CELZ 41.15
- SBFM 39.58
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.